People living with HIV may also have to manage other health conditions like cardiovascular disease, type 2 diabetes, ...

Detailed price information for Assembly Biosciences (ASMB-Q) from The Globe and Mail including charting and trades.

MB-108 shows activity and is well tolerated in recurrent glioblastoma, with preclinical data supporting its combination with ...

MB-108 (HSV-1 oncolytic virus) is active and well tolerated in patients with recurrent glioblastoma in ongoing Phase 1 clinical trialPreclinical ...

Candel Therapeutics aims to revolutionize cancer treatment with oncolytic virus therapy, awaiting crucial trial results in Q4 ...

India vs New Zealand Highlights, 2nd Test Day 2: New Zealand took command of the ... The batters then came out with positive intent and stretched the lead over 300 runs which looks massive on ...

Overall, patients in the trial had a 22.2% objective response rate (ORR ... with high levels of HER2 expression (known as HER2-positive). In the new trial of tucatinib and trastuzumab without ...

But when your breast cancer is described as HER2-positive, it means the cancer cells have more HER2 protein than usual. Since this protein can make cancer cells grow more quickly, it’s natural ...

Bel-Sar For The Treatment Of Patients With Choroidal Melanoma As I stated above, Aura Biosciences was able to report positive results from its phase 2 open-label study using Bel-sar to treat ...

equivalent to 2.5% of global GDP. This is about $800 billion higher than two years ago, or roughly $570 billion higher, net of inflation. Channelling finance to nature positive solutions will not ...